Ultrasound localization microscopy for evaluation of therapeutic efficacy assessment after transarterial chemoembolization in hepatocellular carcinoma
Open Access
- 28 April 2026
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1786075
Abstract
Objectives: The timely and precise evaluation of the efficacy of Transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) patients facilitates post preventive and therapeutic therapy. This study aimed to demonstrate the significance of ultrasound localization microscopy (ULM) assessment of TACE. Methods: A total of 85 HCC patients underwent initial TACE were retrospectively analyzed. The ULM system automatically calculated relevant metrics, including vessel ratio, mean velocity, and perfusion index. A combined evaluation model was constructed by ULM parameters alongside routine laboratory indicators (AFP, WBC, RBC, ALP) selected via Random Forest and Logistic algorithm. Results: The combined model achieved an Area Under the Curve (AUC) of 0.915 in assessing TACE efficacy. The model demonstrated excellent calibration with a mean absolute error of 0.076 in clinic decision probabilities. Conclusion: ULM effectively reflects changes in the tumor vasculature in patients with HCC after TACE. Combining with WBC, RBC, ALP, and elevated AFP levels could improve evaluation performance.Keywords
This publication has 18 references indexed in Scilit:
- Ultrasound Localization Microscopy for the Assessment of Microvascular Abnormalities in Transplant Renal Artery StenosisUltrasound in Medicine & Biology, 2025
- Relationship between contrast-enhanced ultrasound combined with ultrasound resolution microscopy imaging and histological features of hepatocellular carcinomaAbdominal Radiology, 2025
- Guidelines for standard operation of imaging modalities in orbital diseases (2024)International Journal of Ophthalmology, 2025
- Ultrasonography of Hepatocellular Carcinoma: From Diagnosis to PrognosisJournal of Clinical and Translational Hepatology, 2024
- Neutrophil-to-lymphocyte ratio as an index of treatment response to trans-arterial chemoembolization in hepatocellular carcinoma2024
- Assessment of Transarterial Chemoembolization Using Super-resolution Ultrasound Imaging and a Rat Model of Hepatocellular CarcinomaUltrasound in Medicine & Biology, 2023
- Modified quantitative and volumetric response evaluation criteria for patients with hepatocellular carcinoma after transarterial chemoembolizationFrontiers in Oncology, 2023
- CIRSE Standards of Practice on Hepatic Transarterial ChemoembolisationCardioVascular and Interventional Radiology, 2021
- Abbreviated MRI for Hepatocellular Carcinoma Screening and SurveillanceRadioGraphics, 2020
- Modified RECIST (mRECIST) Assessment for Hepatocellular CarcinomaSeminars in Liver Disease, 2010